EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

A Systematic Review and Meta-Analysis of Tuberculous Preventative Therapy Adverse Events

Luca Melnychuk, Sara Perlman-Arrow, Mayara Lisboa Bastos, Dick Menzies

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciad246 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Luca Melnychuk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, McGill University, Montreal, Canada. Hauptthemen laut MEDLINE: Tuberculosis, Chemical and Drug Induced Liver Injury, Latent Tuberculosis. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tuberculosis preventative therapy (TPT) is a key part of the World Health Organization’s (WHO) end tuberculosis (TB) strategy. However, the occurrence of potentially serious adverse events (AE) is a limitation of TPT regimens. We conducted a systemic review and meta-analysis to estimate the incidence of AE and hepatotoxicity with various TPT regimens to help inform clinical decision making.

Methods

We searched MEDLINE, Cochrane, Health Star, and EMBASE from 1952 to April 2021 for studies reporting AE associated with TPT. Included studies reported AE stratified by regimen and provided the number of participants receiving each regimen. We used a random-effect model to meta-analyze the cumulative incidence of AE.

Results

We included 175 publications describing TPT-related AE in 277 cohorts. Among adults, the incidence of any AE, and hepatotoxicity leading to drug discontinuation was 3.7% and 1.1%, respectively, compared to 0.4% and 0.02%, respectively, in children. The highest incidence of any AE, and AE leading to drug discontinuation was with 3 months isoniazid and rifapentine (3HP), and the lowest was with 4 months rifampin (4R). 4R also had the lowest incidence of hepato-toxic AE and drug discontinuation due to hepato-toxic AE. 3HP also had a low incidence of hepato-toxic AE.

Conclusions

Although our study was limited by variability in methods and quality of AE reporting in the studies reviewed, pediatric populations had a very low incidence of AE with all TPT regimens reviewed. In adults, compared to mono-H regimens all rifamycin-based regimens were safer, although 4R had the lowest incidence of TPT-related AE of all types and of hepatotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TuberculosisChemical and Drug Induced Liver InjuryLatent TuberculosisChildAdultHumansAntitubercular AgentsDrug Therapy, CombinationIsoniazid

Stichwörter der Autor:innen

TB infectionTB preventionadverse eventsdrug-related toxicitytreatment of TB infection

Substanzen

Antitubercular AgentsIsoniazid

Autor:innen und Institutionen

  • Department of Medicine, McGill University, Montreal, Canada.
  • Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, Canada.
  • Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research & Evaluation, Research Institute of the McGill University Health Centre, Montreal, Canada.
  • McGill International TB Centre, McGill University, Montreal, Canada.

Förderung

  • Canadian Institutes of Health Research

Zitieren

APA

Melnychuk, L., Perlman-Arrow, S., Lisboa Bastos, M., & Menzies, D. (2023). A Systematic Review and Meta-Analysis of Tuberculous Preventative Therapy Adverse Events. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad246

Vancouver

Melnychuk L, Perlman-Arrow S, Lisboa Bastos M, Menzies D. A Systematic Review and Meta-Analysis of Tuberculous Preventative Therapy Adverse Events. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciad246

BibTeX
@article{Melnychuk2023,
  author = {Melnychuk, Luca and Perlman-Arrow, Sara and Lisboa Bastos, Mayara and Menzies, Dick},
  title = {A Systematic Review and Meta-Analysis of Tuberculous Preventative Therapy Adverse Events},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciad246}
}
Kostenlos starten →